Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Roche discloses novel mGlu5 receptor positive allosteric modulators

Feb. 3, 2014

Drug developed for diabetes ameliorates experimental SMA

Jan. 31, 2014

Avanir Pharmaceuticals submits NDA for AVP-825 for migraine

Jan. 31, 2014

Michael J. Fox Foundation provides overview of development conducted under its Partnering Program

Jan. 30, 2014

Omeros reports data from phase IIa OMS-824 trial

Jan. 30, 2014

Novel PDE4 inhibitor appears to have limited emetic potential

Jan. 30, 2014

Alcobra reports promising results from new study of MG-01CI in animal model of fragile X syndrome

Jan. 29, 2014

DioGenix discloses new data supporting efficacy of multiple sclerosis assay

Jan. 29, 2014

Researchers at Esteve design novel sigma1 receptor ligands

Jan. 29, 2014

Neuren provides update on phase II trials of NNZ-2566 in four separate neurological disorders

Jan. 28, 2014

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...